Showing results (431-440 of 2,445) with videos related to
Sort By:
Pageof 245
Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2016
Antitumor Response of VEGFR2- and VEGFR3-Amplified Angiosarcoma to PazopanibVinod Ravi, Eric M Sanford, Wei-Lien Wang, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2016
NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016Peter R Carroll, J Kellogg Parsons, Gerald Andriole, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2016
Quality Indicators to Assure and Improve Cancer Care in Spain Using the Delphi TechniqueCarlos Camps, Joan Albanell, Antonio Antón, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
Central nervous system cancers, version 2.2014. Featured updates to the NCCN GuidelinesLouis Burt Nabors, Jana Portnow, Mario Ammirati, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
Approach to the management of incidental venous thromboembolic events in patients with cancerCasey L O'Connell, Howard A LiebmanJournal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
Role of MRI in primary brain tumor evaluationDenise Leung, Xiaosi Han, Tom Mikkelsen, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
Socioeconomic and clinical factors are key to uncovering disparity in accrual onto therapeutic trials for breast cancerCarolyn E Behrendt, Arti Hurria, Lusine Tumyan, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
Where exactly does ponatinib fit in chronic myelogenous leukemia?Ellin BermanJournal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapiesAlan P Venook, Maria E Arcila, Al B Benson, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2016
Cytogenetic Evolution Associated With Disease Progression in Hematopoietic Neoplasms With t(8;22)(p11;q11)/BCR-FGFR1 RearrangementWei Wang, Guilin Tang, Tapan Kadia, et al.Pageof 245